医疗补助的解除:与新的和结束的布普伦诺芬治疗事件的关联
Journal of addiction medicine
|August 21, 2025
概括
医疗补助的撤销扰乱了阿片类药物使用障碍 (OUD) 的布普伦诺芬治疗,增加了情节结束和减少了新的开始. 这些干扰在医疗补助退学率高的州是最明显的.
科学领域:
- 医疗服务研究
- 公共卫生
- 药理学
背景情况:
- 医疗补助是治疗阿片类药物使用障碍 (OUD) 的首要支付人.
- 医疗补助的解除,重新验证资格的过程,可能会影响获得OUD治疗的机会.
- 对于医疗补助的延期对布普伦诺芬治疗的持续性影响知之甚少.
研究的目的:
- 检查医疗补助的解除与布普伦诺芬OUD治疗的变化之间的关联.
- 调查医疗补助退休的规模如何影响布诺芬治疗模式.
主要方法:
- 使用2021-2023年国家零售药房数据的回顾性队列研究.
- 分析已开出的布普伦诺芬处方,以确定新发病和终止治疗.
- 与医疗补助退学规模相关的治疗事件的评估变化.
主要成果:
- 医疗补助计划的终止与医疗补助计划中的布普伦诺芬病例增加了3.0%,新发病例减少了2.6%.
- 医疗补助退休率较高的州治疗结束率较高,新治疗开始率较低.
- 在所有付费者中,终止布诺芬治疗的发作增加了2. 7%,新发作的增长微不足道.
结论:
- 医疗补助计划的终止似乎严重影响了阿片类药物使用障碍的布普伦诺芬治疗.
- 这些发现突显了医疗保险丧失后OUD治疗的潜在障碍和连续性.
- 可能需要采取政策干预措施,以减轻医疗补助计划对弱势患者群体的影响.
更多相关视频
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.3K
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.3K
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
655
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
655
Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
426
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
426
Drug Dependence
1.2K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.2K
Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
